Inhibition by neonatal hypothalamic estrogen implantation of carcinogen-induced mammary tumorigenesis in female rats.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000230:Adenocarcinoma / Q000139:chemically induced; D000232:Adenofibroma / Q000139:chemically induced; D000367:Age Factors; D000818:Animals; D003338:Corpus Luteum / Q000187:drug effects; D004343:Drug Implants; D004967:Estrogens / Q000008:administration & dosage*; D004971:Estrus / Q000187:drug effects; D005260:Female; D007031:Hypothalamus; D007032:Hypothalamus, Anterior; D007033:Hypothalamus, Middle; D007034:Hypothalamus, Posterior; D007247:Infertility, Female / Q000139:chemically induced; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000033:anatomy & histology; D011247:Pregnancy; D051381:Rats; D014621:Vagina / Q000187:drug effects
D004343:Drug Implants; D004967:Estrogens; D015127:9,10-Dimethyl-1,2-benzanthracene